Global data indicate that the prevalence of IBD ranges from 0.5% to 1% in Western nations and is increasing in emerging industrialized countries and may reach 1% in numerous regions by 2030 (1)
This ultimately helps to reduce the total cost of ownership, allowing pharma companies to realize the economic benefits that come along with it
But there was no effect on body weight [7]
Debilitating exhaustion is not an expected or acceptable side effect and requires thorough evaluation
J Thromb Thrombolysis 34(3):318325 Campo G, Pavasini R, Biscaglia S, Ferri A, Andrenacci E, Tebaldi M, Ferrari R (2015) Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment
[16] Weight loss (of greater than 5% of body weight) occurred in 23% of women with axillary node-negative, estrogen-receptor positive breast cancer who received adjuvant tamoxifen (n = 1422) compared with 18% of women who received placebo (n = 1437) following primary surgery in a randomized, double-blind study (the NSABP B-14 study)
![PDF] Switching Between Glucagon-Like Peptide-1 Receptor Agonists: Rationale and Practical Guidance](https://figures.semanticscholar.org/69d84ad0979bcded8fc643f42a28ce77fbc5b3ff/2-Table1-1.png)
